We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

An Efficacy Study of a Single Dose Treatment of PRO-513 for Subjects Suffering a Migraine Attack

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00330850
Recruitment Status : Completed
First Posted : May 29, 2006
Last Update Posted : April 2, 2007
Information provided by:
ProEthic Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Estimated Study Completion Date : December 2006